Zentalis Pharmaceuticals, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2019 | — | $-8.7M | $-8.3M |
| Jun 2019 | — | $-10.6M | $-10.5M |
| Sep 2019 | — | $-12.6M | $-12.3M |
| Dec 2019 | — | $-14.9M | $-14.5M |
| Mar 2020 | — | $-16.4M | $-16.1M |
| Jun 2020 | — | $-27.4M | $-26.9M |
| Sep 2020 | — | $-34.8M | $-34.6M |
| Dec 2020 | — | $-40.2M | $-40.3M |
| Mar 2021 | — | $-50.3M | $-49.9M |
| Jun 2021 | — | $-55.1M | $-54.6M |
| Sep 2021 | — | $-62.9M | $-4.2M |
| Dec 2021 | — | $-48.2M | $-50.1M |
| Mar 2022 | — | $-57.9M | $-59.1M |
| Jun 2022 | — | $-63.5M | $-68.4M |
| Sep 2022 | — | $-54.2M | $-54.4M |
| Dec 2022 | — | $-51.8M | $-55.0M |
| Mar 2023 | $0 | $-65.0M | $-63.2M |
| Jun 2023 | $0 | $-103.9M | $-112.5M |
| Sep 2023 | $0 | $-62.7M | $-55.5M |
| Dec 2023 | $0 | $-67.9M | $-60.9M |
| Mar 2024 | $40.6M | $-24.8M | $10.1M |
| Jun 2024 | $0 | $-65.1M | $-88.3M |
| Sep 2024 | $0 | $-51.4M | $-40.2M |
| Dec 2024 | $26.9M | $-49.8M | $-47.5M |
| Mar 2025 | $0 | $-45.6M | $-48.3M |
| Jun 2025 | $0 | $-36.1M | $-26.9M |
| Sep 2025 | $0 | $-33.7M | $-26.7M |
| Dec 2025 | $0 | $-37.4M | $-35.2M |
| Mar 2026 | — | $-37.9M | $-35.4M |
| Jun 2026 | — | $-44.4M | $-42.3M |